POLYMYXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Polymyxin, and what generic alternatives are available?
Polymyxin is a drug marketed by Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Pharmobedient, Rising, Xellia Pharms Aps, and Paddock Llc. and is included in eight NDAs.
The generic ingredient in POLYMYXIN is polymyxin b sulfate. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Polymyxin
A generic version of POLYMYXIN was approved as polymyxin b sulfate by FRESENIUS KABI USA on January 10th, 2008.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for POLYMYXIN?
- What are the global sales for POLYMYXIN?
- What is Average Wholesale Price for POLYMYXIN?
Summary for POLYMYXIN
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Drug Prices: | Drug price information for POLYMYXIN |
| Drug Sales Revenues: | Drug sales revenues for POLYMYXIN |
| DailyMed Link: | POLYMYXIN at DailyMed |
US Patents and Regulatory Information for POLYMYXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 206589-001 | Apr 4, 2016 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Xellia Pharms Aps | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 202766-001 | Jan 15, 2014 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 060716-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Paddock Llc | POLYMYXIN B SULFATE | polymyxin b sulfate | POWDER;FOR RX COMPOUNDING | 062455-001 | Jul 27, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 065372-001 | Jan 10, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
